Search Results - "Mello, Celso A"
-
1
Does the Addition of Mutations of CTNNB1 S45F to Clinical Factors Allow Prediction of Local Recurrence in Patients With a Desmoid Tumor? A Local Recurrence Risk Model
Published in Clinical orthopaedics and related research (01-10-2023)“…The initial approach to the treatment of desmoid tumors has changed from surgical resection to watchful waiting. However, surgery is still sometimes considered…”
Get full text
Journal Article -
2
HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors
Published in Therapeutic advances in medical oncology (01-01-2023)“…Background: Nearly 30% of neuroendocrine tumors (NETs) have evidence of immunohistochemical (IHC) expression of estrogen (ER) and/or progesterone (PR)…”
Get full text
Journal Article -
3
Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer
Published in Cancer biology & therapy (02-09-2015)“…Background: Quantification of Circulating Tumor Cells (CTCs) as a prognostic marker in metastatic colorectal cancer (mCRC) has already been validated and…”
Get full text
Journal Article -
4
Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion
Published in OncoTargets and therapy (01-01-2014)“…Sarcomas are rare and heterogeneous neoplasms with poor prognosis that are thought to spread to distant organs mainly by hematogenous dissemination. However,…”
Get full text
Journal Article -
5
Circulating Tumor Cells in Desmoid Tumors: New Perspectives
Published in Frontiers in oncology (14-09-2021)“…Desmoid tumor (DT) is a rare neoplasm with high local recurrence rates, composed of fibroblastic cells that are characterized by the expression of key…”
Get full text
Journal Article -
6
Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients
Published in Cells (Basel, Switzerland) (26-06-2019)“…Neoadjuvant chemoradiation (NCRT) followed by total mesorectal excision is the standard treatment for locally advanced rectal cancer (LARC). To justify a…”
Get full text
Journal Article -
7
Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients
Published in World journal of surgical oncology (19-09-2012)“…Gastric cancer relapse occurs in about 30% of the patients treated with gastrectomy and D2-lymphadenectomy, mainly as distant or peritoneal metastases…”
Get full text
Journal Article -
8
Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
Published in Frontiers in oncology (22-03-2022)“…The clinical and pathological responses to multimodal neoadjuvant therapy in locally advanced rectal cancers (LARCs) remain unpredictable, and robust…”
Get full text
Journal Article -
9
Mutation Detection in Tumor-Derived Cell Free DNA Anticipates Progression in a Patient With Metastatic Colorectal Cancer
Published in Frontiers in oncology (10-08-2018)“…The observation of tumor-derived cell-free DNA (ctDNA) in plasma brought new expectations to monitor treatment response in cancer patients. In an exploratory…”
Get full text
Journal Article -
10
Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a single cancer center
Published in Radiation oncology (London, England) (15-10-2012)“…Adjuvant chemoradiotherapy is part of a multimodality treatment approach in order to improve survival outcomes after surgery for gastric cancer. The aims of…”
Get full text
Journal Article -
11
Impact of ypT, ypN, and Adjuvant Therapy on Survival in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery
Published in Annals of surgical oncology (01-10-2019)“…Background Perioperative chemotherapy and surgery is the standard of care in advanced gastroesophageal cancer patients, but its impact among those treated with…”
Get full text
Journal Article -
12
Prolonged time to progression with fulvestrant for metastatic breast cancer
Published in Medical oncology (Northwood, London, England) (01-06-2011)“…Although the incidence of breast cancer has been declining in recent years, the disease is still one of the leading causes of cancer deaths in women. Recently,…”
Get full text
Journal Article -
13
PD‐L1 expression in gastric and gastroesophageal junction cancer patients treated with perioperative chemotherapy
Published in Journal of surgical oncology (01-07-2022)“…Background and Objectives The incidence, predictive, and prognostic impact of programmed cell death (PD‐L1) expression in gastric (GC) and gastroesophageal…”
Get full text
Journal Article -
14
Prognostic impact of MUM1 expression by immunohistochemistry on primary mediastinal large B-cell lymphoma
Published in Leukemia & lymphoma (01-08-2011)“…Diffuse large B-cell lymphoma can be classified into two prognostically distinct subgroups with germinal center B-cell-like (CG) and activated B-cell-like…”
Get full text
Journal Article -
15
Outcomes of Patients With Metastatic Anal Cancer According to HIV Infection: A Multicenter Study by the Latin American Gastrointestinal Oncology Group (SLAGO)
Published in Clinical colorectal cancer (01-12-2021)“…HIV-positive patients are underrepresented in clinical trials of metastatic squamous cell carcinoma of the anal canal (mSCCA). We aimed to compare the clinical…”
Get full text
Journal Article -
16
Disease-Free Survival and Time to Complete Response After Definitive Chemoradiotherapy for Squamous-Cell Carcinoma of the Anus According to HIV Infection
Published in Clinical colorectal cancer (01-09-2020)“…The standard treatment for localized squamous-cell carcinoma of the anal canal is definitive chemoradiotherapy. A meta-analysis of published studies conducted…”
Get full text
Journal Article -
17
Influence of proton pump inhibitors on the pathological response of rectal cancer: a multicentre study
Published in Ecancermedicalscience (2023)“…The standard neoadjuvant therapy for rectal cancer involves fluoropyrimidines and radiotherapy and, most recently, total neoadjuvant therapy (TNT). A drug-drug…”
Get full text
Journal Article -
18
Neoadjuvant Hypofractionated Radiotherapy and Chemotherapy in High-Grade Extremity Soft Tissue Sarcomas: Phase 2 Clinical Trial Protocol
Published in JMIR research protocols (25-05-2017)“…Neoadjuvant radiotherapy (RT) and chemotherapy are applied to large, high-grade extremity soft tissue sarcomas to treat metastatic disease earlier and…”
Get full text
Journal Article -
19
Evaluation of estrogen receptor alpha, estrogen receptor beta, progesterone receptor, and cKIT expression in desmoids tumors and their role in determining treatment options
Published in Bioscience trends (01-02-2010)“…The present study evaluates the protein expression of estrogen receptor alpha (ERalpha), estrogen receptor beta (ERbeta), progesterone receptor (PR) and cKIT…”
Get full text
Journal Article -
20
Predictors of peritoneal carcinomatosis in patients with gastric cancer treated at a single institution in Brazil
Published in Journal of surgical oncology (01-11-2009)“…Background Peritoneal carcinomatosis is a common pattern of recurrence in gastric cancer and is associated with a poor prognosis. Determining predictive…”
Get full text
Journal Article